Himmelfarb J, Vanholder R, Mehrotra R et al (2020) The current and future landscape of dialysis. Nat Rev Nephrol 16:573–585

Article  PubMed  PubMed Central  Google Scholar 

Jha V, Wang AY-M, Wang HY (2012) The impact of CKD identification in large countries: the burden of illness. Nephrol Dial Transplant 27(suppl 3):32–38

Article  Google Scholar 

The World Health Organization Quality of Life Assessment (1998) (WHOQOL): development and general psychometric properties. Soc Sci Med 46:1569–1585

Article  Google Scholar 

Callahan D, The WHO (1973) Definition of health. Hastings Center Stud 1(3):77–87

Article  CAS  Google Scholar 

Baiardi F, Esposit ED, Cocechi R, Fabri A, Sturani A, Valpiani G et al (2002) Effects of clinical and individual variables on quality of life in chronic renal failure patients. J Nephrol 15(1):61–67

PubMed  Google Scholar 

Hall RK, Luciano A, Pieper C, Colón-Emeric CS (2018) Association of Kidney Disease Quality of Life (KDQOL-36) with mortality and hospitalization in older adults receiving hemodialysis. BMC Nephrol 19:11. https://doi.org/10.1186/s12882-017-0801-5

Article  PubMed  PubMed Central  Google Scholar 

Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, McMurray JJ, Murray H, Steenkamp R, Tomson CRV, Wheeler CD, Winearls CG, Ford I on behalf of the PIVOTAL Study investigators (2019) Randomised controlled trial comparing high-dose versus low-dose intravenous iron supplementation in haemodialysis (PIVOTAL). N Engl J Med 380(5):447–458

Article  CAS  PubMed  Google Scholar 

Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, McMurray JJ, Murray H, Steenkamp R, Tomson CRV, Wheeler CD, Winearls CG, Ford I on behalf of the PIVOTAL Study investigators (2018) Randomised controlled trial comparing high-dose versus low-dose intravenous iron supplementation in haemodialysis (PIVOTAL): rationale, study design, and baseline data. Am J Nephrol 48(4):260–268

Article  CAS  PubMed  Google Scholar 

Brazier J, Jones N, Kind P (1993) Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 2:169–180

Article  CAS  PubMed  Google Scholar 

Williams A, Buxton M, O’Hanlon M, Rushby J, Pekurinen M, Sintonen H, Bjork S, Lindgren B, Perrson U, Brooks R, Nord E, Allison R, Butler C, Rabin R, Rosser R, Selai C, Bonsel G, Essink-Bot ML, van Hout B, deCharro F, Gudex C, Kind P (1990) EuroQol: a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16:199–208

Article  Google Scholar 

Manns BJ, Johnson JA, Taub K, Mortis G, Ghali WA, Donaldson C (2002) Dialysis adequacy and health related quality of life in hemodialysis patients. Asaio J 48:565–569

Article  PubMed  Google Scholar 

Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, Westlake L (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160–164

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joshi VD, Mooppl V, Lim J (2010) Validation of the Kidnet Disease Quality of life Short Form: a cross sectional study of a dialysis-targeted health measure in Singapore. BMC Nephrol 11:36

Article  PubMed  PubMed Central  Google Scholar 

Czyzewki L, Sacko-Rimer J, Wyzzet S, kwowski A (2014) Assessment of HRQoL of patients after kidney transplantationin comparison to haemodialysis and peritoneal dialysis. Ann Transplant 70:576–585

Google Scholar 

Lewis EF, Pfeffer MA, Feng A, Uno H, McMurray JJV, Toto R, Gandra SR, Solomon SD, Moustafa M, Macdougall IC, Locatelli F, Parfrey S, for the TREAT Investigators (2011) Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial. Clin J Am Soc Nephrol 6:845–855

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mapes DL, Lopes AA, Satayathum S, Cullough KP, Goodkin DA, Locatelli F et al (2003) Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 64(1):339–349

Article  PubMed  Google Scholar 

Lowrie EG, Curtin RB, LePain SD (2003) Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis 41(6):1286–1292

Article  PubMed  Google Scholar 

Perl J, Karaboyas A, Morgenstern H, Sen A, Rayner HC, Vanholder RC et al (2017) Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS. Nephrol Dial Transplant 32(3):521–527

PubMed  Google Scholar 

kalantar Zadeh K, Kopple J, Block G, Humohreys MH (2002) Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 12(12):2797–2806

Article  Google Scholar 

Kurella Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE (2001) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361(16):1539–1547

Article  Google Scholar 

Liem YS, Bosch JL, Hunink MM (2008) Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health 11:733–741

Article  PubMed  Google Scholar 

Lopes AA, Bragg-Gresham JL, Goodkin DA, Fukuhara S, Mapes DL, Young EW, Gillespie BW, Akizawa T, Greenwood RN, Andreucci VE, Akiba T, Held PI, Port FK (2007) Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Qual Life Res 16:545–557

Article  PubMed  Google Scholar 

Dhesnaye NC, Meuleman Y, de Rooij ENM, Hoogeveen EK, Dekker FW, Evans M, Pagels AA, Caskey FJ, Tornio C, Porto G, Szymczak M, Drechsler C, Wanner C, Jager KJ, the EQUAL Study Investigators (2022) Health-related Quality-of-life trajectories over time in older men and women with advanced chronic kidney disease. Clin J Am Soc Nephrol 17:205–214

Article  Google Scholar 

Ishiwatari A, Yamamoto S, Fukuma S, Hasegawa T, Wakai S, Nangaku M (2020) Changes in quality of life in older hemodialysis patients: a cohort study on dialysis outcomes and practice patterns. AM J Nephrol 51:650–658

Article  PubMed  Google Scholar 

Dowling TC (2007) Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: an overview. Am J Health Syst Pharm 64(13 Suppl 8):S3-7 (4)

Article  PubMed  Google Scholar 

Perlman RL, Finkelstein FO, Liu L et al (2005) Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the renal research institute-CKD study. Am J Kidney Dis 45:658–666

Article  PubMed  Google Scholar 

Mujais SK, Stor K, Brouillette J, Takano T, Soroka S, Franek C, Mendelssohn D, Frederic O (2009) Health-related quality of life in CKD patients: correlates and evolution over time. Clin J Am Soc Nephrol 4:1293–1301

Article  PubMed  PubMed Central  Google Scholar 

Kimel M, Leidy NK, Mannix S, Dixon J (2008) Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease. Value Health 11:57–75

Article  PubMed  Google Scholar 

Leaf DE, Goldfarb DS (2009) Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia. Kidney Int 75:15–24

Article  CAS  PubMed  Google Scholar 

Drüeke TB, Locatelli F, Clyne N et al (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355:2071–2084

Article  PubMed  Google Scholar 

Bhandari S, Kalra P, Berkowitz M, Belo D, Thomsen LL, Wolf M (2021) Safety and efficacy of iron isomaltoside 1000/ferric derisomaltoside veruss iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial. Nephrol Dial Transplant 36(1):111–120

Article  CAS  PubMed  Google Scholar 

Kassianides X, Gordon A, Sturmey R, Bhandari S (2021) The comparative effect of intravenous iron on oxidative stress and inflammation in patients with Chronic kidney Disease (CKD). A randomized controlled-plot study. Kidney Res Clin Pract. 40(1):89–98

Article  PubMed  PubMed Central  Google Scholar 

Bhandari S, Allgar V, Lamplugh A, Macdougall I, Kalra PA (2021) A multicentre prospective double blinded randomised controlled trial of intravenous iron (Ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with Chronic Kidney Disease on functional status. BMC Nephrol 22:115

Article  CAS  PubMed  PubMed Central  Google Scholar 

Finkelstein FO, van Nooten F, Wiklund I, Trundell D, Cella D (2018) Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy-Anemia (FACT-An) in patients with anemia associated with chronic kidney disease. Health Qual Life Outcomes 16:111

Article  PubMed  PubMed Central  Google Scholar 

Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339:584–590

Article  CAS  PubMed  Google Scholar 

Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D (2007) Anaemia of CKD—the CHOIR study revisited. Nephrol Dial Transplant 22(7):1806–1810

Article  PubMed  Google Scholar 

Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, Investigators C (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355:2085–2098

Article  CAS  PubMed  Google Scholar 

Hazara AM, Bhandari S (2020) Early mortality rates after commencement of maintenance haemodialysis: a systematic review and meta-analysis. Ther Apher Dial 24(3):275–284

Article  PubMed